Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Example of details involved in acquisition talks: like ONCY
View:
Post by Noteable on Oct 11, 2023 2:48pm

Example of details involved in acquisition talks: like ONCY

OT: Details behind $5.7B Danaher acquisition of Abcam

UK-based Abcam revealed more details behind its $5.7 billion acquisition by Danaher, including the dozens of potential buyers the company engaged with as well as internal and external turmoil with Abcam’s founder and former CEO Jonathan Milner over the performance of the company, the makeup of the board and the deal with Danaher.

https://otp.investis.com/clients/uk/abcamplc2/sec/sec-show.aspx?Type=html&FilingId=16974085&CIK=0001492074&Index=10000#d878585dex991_htm
Comment by pelaboost on Oct 11, 2023 5:29pm
Idle Thoughts on a Wednesday Evening. This is not easy to handicap; it is not meant to be easy. From my lay perspective; PanCAN may be the best thing that could have happened to ONC/Y shareholders. They have a broad reach in the medical world, and exceptional guidance for pancreatic patients. Not to mention the brighter light now shining on pelareorep. I do expect that Roche will sidle up in ...more  
Comment by Azzak34 on Oct 11, 2023 5:35pm
Ah, a nice logical, reasoned post. Pancan is only good news, the additional arm is even better news. Speculating on what's happening or not happening is not smart. We're in good shape, aside from the share price.  Waiting for the news, which I expect to be very good. 
Comment by Angler101 on Oct 11, 2023 6:05pm
Just think about how highly unlikely it is that the news will be bad......after all the excellent trial results we’ve had in multiple trials with collaborations with what, 4 or 5 big pharmas, and then PanCAN coming on board, not once but twice, which all but guarantees approval and then approval soon after in the second indication......does anybody really believe that now, all of a sudden we’re ...more  
Comment by fox7mf on Oct 11, 2023 8:21pm
Anyone catch the parabolic upward movement (+4000% at one pt) Tempest Therapeutics had based on positive liver cancer data? Anyone think Oncy can mirror this market reaction during ESMO?
Comment by jh1970 on Oct 11, 2023 8:41pm
What we will get at ESMO ?
Comment by canadafan on Oct 12, 2023 1:45am
The ESMO , conference is about 10 days from now. Not Onc , but two outside trial managers will be presenting two posters/ abstracts. they will be detailing results, I believe one on MBc & the other on pancancer. based on previous conferences comments, the expectation is to have some very spectacular results. The abstracts have been in possession of ESMO for a while. All under embargo. Meaning ...more  
Comment by fox7mf on Oct 12, 2023 3:56am
ESMO, like ASCO will have zero impact on the SP. The market is waiting to see if there's any definitive BP interest in Oncy, which remains to be seen...still.....
Comment by Azzak34 on Oct 12, 2023 5:20am
You're wrong. It adds more updated data to a collection of already positive data. I know you're all Debbie downer but posting illogical negativity won't help. 
Comment by Lesalpes29 on Oct 12, 2023 6:19am
Most or all of the Esmo and Asco prsentations never  had positive impacts on the SP. I remember one a couple year ago when the SP was close to 5$ CAD, a slow decline of the SP followed and look where we stand! We need a clear sign of BP interest (NR) or wonerfull results well appreciated by the markets. Fingers crossed! GL
Comment by Azzak34 on Oct 12, 2023 7:23am
We are building a case for accelerated approval and adding data to show our value to BP. Enough with what happened years ago. We've never been so advanced with our results or close to Phase 3. Communication has been garbage as has shareholder value but stop conflating old news with what we have now. 
Comment by fox7mf on Oct 12, 2023 8:58am
I am a downer with this management, I full on admit it. Many investors are. My point was ESMO will not move the needle share price wise. We all know that to be true. If at ESMO, AA is announced,  or a partner is announced then the SP goes up. If it's just more great data, and it will be, we'll see a 10 cent rocket...wow!!!! 
Comment by Azzak34 on Oct 12, 2023 9:26am
Your continued negative sentiment hurts us all and only adds fuel to the Fud fire. Is that the plan? 
Comment by fox7mf on Oct 12, 2023 9:28am
Enough with the laughable accusations. I'm positive towards the science and will be the same towards mgmt when they follow through on a few things. 
Comment by Azzak34 on Oct 12, 2023 9:30am
What accusations? Your continued negative posts and sentiment? That's laughable or fact? 
Comment by Lesalpes29 on Oct 12, 2023 10:21am
Azzak you have to agree that Matt was completly out with several calls since one year. Fox is using this BB as a tension breaker! Lol
Comment by Azzak34 on Oct 12, 2023 10:29am
I've stated as much myself. Management has been atrocious in communication and shareholder value, that's inarguable. But the daily barage of FUD will not raise the SP. It only hurts us all collectively as negativity among shareholders about upcoming data releases etc only bolsters the bashers case. It's totally self destructive and incredibly weak. If you're not happy you have the ...more  
Comment by Quentin30 on Oct 12, 2023 2:51pm
actually Azzak, I wouldn't say the science is 'unequivocal' yet... remember, even for this PanCan trial, the go/no go decision won't be until early 2025. That means precisely that there is still great risk here... For the past five years, every trial ONCY has conducted has not been powered to show statistical signifiance. It's a glaring error in management I think, but ...more  
Comment by Azzak34 on Oct 12, 2023 2:56pm
Aren't you the "maybe the pancreatic cancer cure person ingested something to cure their cancer, or it was a placebo effect? You have zero credibility here.  I bought more today so you ain't convincing me of anything other than your stupidity. G and FY dope. 
Comment by Quentin30 on Oct 12, 2023 3:28pm
great.. buy as much as you like... and when it drops again tomorrow and into next week, you can get even more.. ONCY gives plenty of buying opportunities... The reason for the poor price performance is precisely because there are still unknowns regarding efficacy...  I don't need you to accept what I'm saying os true Azzak. The p^%& poor stock performance, continued missed ...more  
Comment by Azzak34 on Oct 12, 2023 3:35pm
Who cares what you'd do?! Your commentary on the science is as bad as the share price. Enjoy these days clown, I'll keep loading the boat and send you a postcard from wherever I end up!!  Sort your spell check out, it's gone rogue again. 
Comment by Quentin30 on Oct 12, 2023 4:06pm
Keep hoping Azzak... only way to make money on this stock is to trade it... By early 2025, they will have some other unicorn that will bring riches, and will only take another 12 months... 26 years of pulling the same old magic show... yah, it's different this time...!!
Comment by Azzak34 on Oct 12, 2023 4:09pm
Quentin you have no idea what's going on in a fish market never mind the stock market. You are not a bright guy, it's better if you start to see that. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities